The Food and Drug Administration has approved the PI3K inhibitor Piqray (alpelisib) for the treatment of postmenopausal women, and men, with HR-positive, HER2-negative, PIK3CA-mutated, advanced or metastatic breast cancer following progression on or after an endocrine-based regimen.
From World Blood Cancer Day to today’s top performers fundraising for lifesaving research, here’s what’s making headlines in the cancer space this week.
When you are lost you ask, "Where am I?" When you go through cancer, it is hard to find where you are. In the map of life, why not find yourself where you are in this very moment? You are here.
Two oncology dietitians weigh in on the results of a recent study that show a low-fat diet rich in fruits, vegetables and grains can reduce the risk of dying from breast cancer.
A two-time cancer survivor finds cancer worries a little easier to face with time and experience.
Patients who self-report their symptoms live longer than those who do not, researchers say. Here’s why and what it means for the future of cancer treatment.
Stephanie Seban explains the hurdles she faced as she received the wrong treatment for nearly five years.
Lorén Barbosa, co-chairperson of More Than Friends, discussed the Latino/Caribbean/American organization's Annual Tea Party and the their goal of sending a message of overall health and wellness.
A breast cancer survivor remembers an inconvenient Mother’s Day phone call as he celebrates five years of being cancer-free.
Breast cancer survivors may find symptom relief through at-home acupressure, according to study findings.
In this episode of CURE® Talks Cancer, we spoke with an advocate who is raising awareness around the recent controversy surrounding a certain type of breast implant that is causing a rare type of lymphoma.
More Than Friends chairperson Elise Bourne-Busby talked about her breast cancer journey and the inspiration for the Latino/Caribbean/American initiative that is dedicated to servicing cancer survivors.
At 42,000 US deaths a year, the push to call metastatic breast cancer "chronic" is premature.
The FDA approved Kadcyla for adjuvant treatment of patients with HER2-positive early breast cancer who have residual invasive disease after neoadjuvant taxane and Herceptin-based treatment.
Here are the top 5 CURE stories for April 2019.
Researchers examined the prevalence of chronic opioid use among survivors of breast, colorectal and lung cancer.
I didn't see how alone I was with cancer until I found purpose and friendships with advocacy.
Barbara Bittner, RN, OCN, a finalist for the CURE® Extraordinary Healer® Award for Oncology Nursing, talked about her advocacy work with Charlene’s Dream – a community-based cancer resource center for women.
I'm often asked how things are going with my male breast cancer diagnosis. What's the right answer?
Susan G. Komen Greater NYC to honor exceptional and inspiring individuals and organizations at its annual Impact Awards May 22, 2019 Cipriani 42nd Street.
Menopausal women who take hormonal therapy after surgery for breast cancer may be prone to long-term “chemo brain” – potentially benefitting from cognitive therapy or other interventions.
How a single phone call can change cancer outcomes and improve patient lives.
Entertainment journalist and breast cancer survivor Giuliana Rancic shared her cancer journey before she presented at the 2019 Extraordinary Healer Award for Oncology Nursing.
Although Minority Health Awareness Month is drawing to an end, the fight for equity in healthcare isn’t over.
In this week’s episode, we spoke with entertainment journalist Giuliana Rancic, who discussed her breast cancer journey and how, at the end of the day, she continued to tell herself, “This, too, shall pass.”